Keywords: Perioperative management, GLP1 receptor agonists, GIP agonists, SGLT2 inhibitors, Diabetic ketoacidosis, Aspiration risk, Glycemic control, Preoperative fasting, Obesity management, Anesthesia safety, Cardiorenal protection, Consensus guidelines, Shared decision-making, Perioperative complications.
Newer agents including dual and triple incretin agonists are demonstrating even greater metabolic effects in clinical trials
Op basis van de huidige inzichten lijkt het dat de positieve effecten van carnitinesuppletie op het hart en de bloedvaten zwaarder wegen
Dnde lo encuentras
The food industry deliberately confuses people, says Hyman
Medical Condition Adjustments: The Sixth Key Guideline Adjusting B12 doses is key for people with health issues that affect how nutrients are absorbed